CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -190.28 Million USD | -148.37% |
| 2022 | -76.61 Million USD | -149.86% |
| 2021 | -30.66 Million USD | -63.85% |
| 2020 | -18.71 Million USD | 14.81% |
| 2019 | -21.96 Million USD | 53.02% |
| 2018 | -46.75 Million USD | 15.71% |
| 2017 | -55.46 Million USD | -40.54% |
| 2016 | -39.46 Million USD | -187.95% |
| 2015 | -13.7 Million USD | -1855.06% |
| 2014 | 781 Thousand USD | 122.05% |
| 2013 | -3.54 Million USD | 29.99% |
| 2012 | -5.05 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -7.4 Million USD | -431.42% |
| 2024 Q2 | -1.39 Million USD | 91.63% |
| 2024 Q1 | -16.65 Million USD | 85.89% |
| 2023 Q1 | -23.74 Million USD | -29.57% |
| 2023 Q2 | -24.95 Million USD | -5.07% |
| 2023 Q4 | -118.09 Million USD | -402.86% |
| 2023 Q3 | -23.48 Million USD | 5.88% |
| 2023 FY | -190.28 Million USD | -148.37% |
| 2022 Q4 | -18.32 Million USD | -8.21% |
| 2022 FY | -76.61 Million USD | -149.86% |
| 2022 Q1 | -19.64 Million USD | -21.65% |
| 2022 Q2 | -21.69 Million USD | -10.43% |
| 2022 Q3 | -16.93 Million USD | 21.93% |
| 2021 FY | -30.66 Million USD | -63.85% |
| 2021 Q1 | -687 Thousand USD | 80.46% |
| 2021 Q4 | -16.15 Million USD | -35.76% |
| 2021 Q3 | -11.89 Million USD | -517.38% |
| 2021 Q2 | -1.92 Million USD | -180.49% |
| 2020 Q2 | -6.55 Million USD | -12.62% |
| 2020 FY | -18.71 Million USD | 14.81% |
| 2020 Q1 | -5.82 Million USD | -21.9% |
| 2020 Q4 | -3.51 Million USD | -24.73% |
| 2020 Q3 | -2.81 Million USD | 57.03% |
| 2019 Q4 | -4.77 Million USD | -163.49% |
| 2019 Q2 | -7.84 Million USD | -4.2% |
| 2019 FY | -21.96 Million USD | 53.02% |
| 2019 Q1 | -7.53 Million USD | -100.56% |
| 2019 Q3 | -1.81 Million USD | 76.9% |
| 2018 Q4 | -3.75 Million USD | 81.2% |
| 2018 FY | -46.75 Million USD | 15.71% |
| 2018 Q3 | -19.97 Million USD | -42.01% |
| 2018 Q2 | -14.06 Million USD | -56.78% |
| 2018 Q1 | -8.96 Million USD | 71.68% |
| 2017 Q1 | -5.56 Million USD | 64.07% |
| 2017 FY | -55.46 Million USD | -40.54% |
| 2017 Q4 | -31.67 Million USD | -121.97% |
| 2017 Q3 | -14.26 Million USD | -259.58% |
| 2017 Q2 | -3.96 Million USD | 28.66% |
| 2016 Q2 | -10.33 Million USD | -5.98% |
| 2016 Q1 | -9.75 Million USD | -104.79% |
| 2016 FY | -39.46 Million USD | -187.95% |
| 2016 Q3 | -3.76 Million USD | 63.58% |
| 2016 Q4 | -15.48 Million USD | -311.26% |
| 2015 Q1 | -2.27 Million USD | -45340.0% |
| 2015 FY | -13.7 Million USD | -1855.06% |
| 2015 Q4 | -4.76 Million USD | -36.49% |
| 2015 Q3 | -3.48 Million USD | -9.54% |
| 2015 Q2 | -3.18 Million USD | -40.18% |
| 2014 FY | 781 Thousand USD | 122.05% |
| 2014 Q2 | 877 Thousand USD | 167.25% |
| 2014 Q4 | -5000.00 USD | -100.41% |
| 2014 Q3 | 1.21 Million USD | 38.31% |
| 2014 Q1 | -1.3 Million USD | -132.03% |
| 2013 Q3 | -830 Thousand USD | -3.49% |
| 2013 Q1 | -1.34 Million USD | 0.0% |
| 2013 FY | -3.54 Million USD | 29.99% |
| 2013 Q2 | -802 Thousand USD | 40.5% |
| 2013 Q4 | -562 Thousand USD | 32.29% |
| 2012 FY | -5.05 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -115.056% |
| Biodesix, Inc. | -52.14 Million USD | -264.906% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2297.426% |
| Castle Biosciences, Inc. | -57.46 Million USD | -231.124% |
| DarioHealth Corp. | -59.42 Million USD | -220.198% |
| Exact Sciences Corporation | -204.14 Million USD | 6.792% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 122.518% |
| Illumina, Inc. | -1.16 Billion USD | 83.61% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -1773.472% |
| iSpecimen Inc. | -11.09 Million USD | -1614.349% |
| Standard BioTools Inc. | -74.65 Million USD | -154.881% |
| 23andMe Holding Co. | -666.7 Million USD | 71.459% |
| Medpace Holdings, Inc. | 282.81 Million USD | 167.283% |
| NeoGenomics, Inc. | -87.96 Million USD | -116.31% |
| Inotiv, Inc. | -105.14 Million USD | -80.982% |
| Psychemedics Corporation | -4.15 Million USD | -4480.741% |
| Prenetics Global Limited | -62.72 Million USD | -203.368% |
| Precipio, Inc. | -5.85 Million USD | -3151.051% |
| RadNet, Inc. | 3.04 Million USD | 6351.117% |
| Sotera Health Company | 51.37 Million USD | 470.375% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -12192.248% |
| Exagen Inc. | -23.68 Million USD | -703.259% |
| Natera, Inc. | -434.8 Million USD | 56.237% |
| Aspira Women's Health Inc. | -16.69 Million USD | -1040.108% |
| Neogen Corporation | -9.42 Million USD | -1919.786% |
| Myriad Genetics, Inc. | -112 Million USD | -69.896% |
| ICON Public Limited Company | 612.33 Million USD | 131.075% |
| Bionano Genomics, Inc. | -232.49 Million USD | 18.155% |
| Check-Cap Ltd. | -17.56 Million USD | -983.128% |
| Twist Bioscience Corporation | -208.72 Million USD | 8.836% |
| Guardant Health, Inc. | -479.44 Million USD | 60.312% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -7137.767% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -13.382% |
| Sera Prognostics, Inc. | -36.24 Million USD | -425.037% |
| OPKO Health, Inc. | -188.86 Million USD | -0.752% |
| Personalis, Inc. | -108.29 Million USD | -75.707% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -1812.967% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -12192.248% |
| MDxHealth SA | -43.1 Million USD | -341.494% |
| Prenetics Global Limited | -62.72 Million USD | -203.368% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -1791.444% |
| Mainz Biomed B.V. | -26.29 Million USD | -623.631% |
| Trinity Biotech plc | -24.01 Million USD | -692.256% |
| Neuronetics, Inc. | -30.18 Million USD | -530.309% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2297.426% |